Think It’s Too Late to Buy Vertiv? Here’s Why the $15 Billion Backlog Says Otherwise

Photo of Austin Smith
By Austin Smith Published

Quick Read

  • Vertiv (VRT) trades at 46x forward P/E with 42%-45% projected EPS growth through 2026, yielding a PEG ratio of 1.77, while the company’s order backlog surged to $15 billion with a 2.9x book-to-bill ratio that provides clear visibility into continued revenue acceleration.

  • Vertiv’s explosive order growth is driven by AI infrastructure buildout demand concentrated in the Americas, though APAC and EMEA revenue declines and insider selling at elevated prices signal execution risks if data center spending momentum slows.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Think It’s Too Late to Buy Vertiv? Here’s Why the $15 Billion Backlog Says Otherwise

© 24/7 Wall St.

Vertiv Holdings (NYSE:VRT | VRT Price Prediction) has risen 347% over the past year, climbing from $62.82 to $281.03. If you watched that move from the sidelines, the question burning in your mind right now is obvious: is there anything left here, or has the stock already priced in the upside?

The honest answer requires working through three things: what the valuation actually looks like today, whether the business has real catalysts ahead, and what the downside looks like if you buy now. Let’s go through each.

Valuation: Elevated, but Not Irrational Given the Growth

At $281.03, Vertiv trades at a trailing P/E of 83x and a forward P/E of 46x based on analyst estimates. Those numbers will make any value investor wince. But context matters here. Vertiv guided 2026 adjusted diluted EPS of $5.97 to $6.07, representing 42% to 45% growth over 2025. That EPS growth rate is not a rounding error — it is the kind of acceleration that compresses forward multiples fast. The PEG ratio sits at 1.77, which is elevated but not extreme for a company growing earnings at this pace. The consensus analyst price target is $271.25, which is actually below the current price — a signal that the stock has run past near-term Wall Street expectations. Investors buying above the consensus target are betting on estimate revisions, not current Wall Street consensus.

Forward Catalyst: The Backlog Tells the Story

The most compelling reason this move may not be over is Vertiv’s order book. Q4 2025 organic orders grew 252% year over year — the strongest order quarter in company history. The backlog now stands at $15 billion, up 109% year over year, with a book-to-bill ratio of approximately 2.9x. That ratio means for every dollar of product shipped, Vertiv is booking nearly three dollars in new orders. CEO Giordano Albertazzi put it plainly on the earnings call: “Our record backlog provides clear visibility into what we expect to be another year of significant growth.”

The near-term catalyst is concrete: Q1 2026 earnings are scheduled for April 22, just 13 days away. Vertiv guided Q1 net sales of $2.5 billion to $2.7 billion and adjusted EPS of $0.95 to $1.01. A beat there, combined with any upward revision to full-year guidance, would add another leg to the move. Beyond Q1, the company has flagged a May 2026 investor conference where management will detail the long-term margin roadmap, including a 25% adjusted operating margin target by 2029.

Risk and Entry: The Downside Is Real

The bear case carries real downside. Vertiv carries a beta of 2.05, meaning it moves roughly twice as fast as the broader market in both directions. The model’s bear-case 12-month target sits at $216.78, implying a potential pullback of nearly 23% from current levels. APAC revenue declined 9.6% and EMEA declined 8.2% in Q4 2025, a reminder that the growth story is heavily concentrated in the Americas. Tariff uncertainty adds an unpredictable cost layer. And several board members — including Director Steven Reinemund, who sold 119,313 shares in late February at prices between $250.14 and $259.09 — took the post-earnings pop as an exit opportunity. That director-level selling at elevated prices deserves attention from anyone buying at $281.

The Verdict

Vertiv is not cheap, and the stock has already priced in a lot of good news. But the business is generating real earnings growth, the backlog provides genuine revenue visibility, and the AI infrastructure buildout driving demand shows no signs of slowing. For a retirement-focused investor, the high beta and stretched valuation make a full position at current prices a difficult proposition. Investors who believe in the long-term data center infrastructure story and can tolerate a 20%-plus drawdown if sentiment shifts should weigh the April 22 earnings report as the next key data point before forming a view on valuation.

Photo of Austin Smith
About the Author Austin Smith →

Austin Smith is a financial publisher with over two decades of experience in the markets. He spent over a decade at The Motley Fool as a senior editor for Fool.com, portfolio advisor for Millionacres, and launched new brands in the personal finance and real estate investing space.

His work has been featured on Fool.com, NPR, CNBC, USA Today, Yahoo Finance, MSN, AOL, Marketwatch, and many other publications. Today he writes for 24/7 Wall St and covers equities, REITs, and ETFs for readers. He is as an advisor to private companies, and co-hosts The AI Investor Podcast.

When not looking for investment opportunities, he can be found skiing, running, or playing soccer with his children. Learn more about me here.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618